Register for our free email digests:
Boston Scientific Corp.
www.bostonscientific.com
Latest From Boston Scientific Corp.
Guidewire, Catheter Draft Guidance Docs Address Coating Risks
US FDA issued two draft guidelines June 14 addressing labeling and performance testing for guidewires and other interventional vascular devices. The draft recommendations address risks that have been identified in recent years resulting from the separation of coating material from the devices during deployment.
Stryker Says It's Not Chasing Boston Scientific
Rumors of a potential Stryker-Boston Scientific coupling have been quashed after the orthopedics player officially stated it is not in discussions with the cardiology company.
9 + 11 = Possible 3: Can A Stryker-Boston Scientific Combo Work?
Unconfirmed rumors of Stryker having approached Boston Scientific about a takeover bid raised eyebrows all around, not least because the move – reported on June 11 – was so unexpected. But would a combination of the medtech industry's No. 9 and No. 11, to create a broad-scale portfolio with very little product overlap, make strategic sense? Reactions have been mixed.
Diversification May Be At Play As Big Pharma Deals With Challenges
Pharmaceuticals have been, and are forecasted to be, the main revenue driver for big pharma, but reliance on this market could shift because of challenges, ranging from generic and biosimilar competition to low R&D productivity. An analysis based on the indicative profit potential metric finds that branded prescription drugs remain the most profitable market to play in, but other sectors may offer opportunities.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Cardiovascular Imaging Systems (CVIS)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
-
Boston Scientific Corp.
- Advanced Stent Technologies Inc.
- Apama Medical Inc.
- Asthmatx Inc.
- Atritech Inc.
- Bard Electrophysiology
- BEI Medical Systems Co. Inc.
- Boston Scientific Japan KK
- BridgePoint Medical Inc.
- Cameron Health Inc.
- Cardiac Pathways Corp.
- CardioGene Therapeutics Inc.
- Cardiovascular Imaging Systems Inc.
- Catheter Innovations Inc.
- Corvita Corp.
- CryoCor Inc.
- CryoVascular Systems Inc.
- Embolic Protection Inc.
- EndoChoice Holdings Inc.
- EndoTex Interventional Systems Inc.
- Enteric Medical Technologies Inc.
- EP Technologies Inc.
- Guidant Corp.
- Heart Technology Inc.
- InFlow Dynamics Inc.
- IntElect Medical Inc.
- Interventional Technologies Inc.
- IoGyn Inc.
- Labcoat Ltd.
- Mansfield
- Mansfield EP
- Meadox Medicals Inc.
- Microvasive Inc.
- MinTec
- nVision Medical Corp.
- Possis Medical Inc.
- Precision Vascular Systems Inc.
- Quanam Medical Corp.
- RadioTherapeutics Corp.
- Remon Medical Technologies Ltd.
- ReVascular Therapeutics Inc.
- Rhythmia Medical Inc.
- Rubicon Medical Corp.
- Sadra Medical Inc.
- Schneider Worldwide
- SciMed Life Systems Inc.
- Smart Therapeutics Inc.
- Symbiosis Corp.
- Symetis SA
- Target Therapeutics Inc.
- Vesica Medical Inc.
- Vessix Vascular Inc.
- XLumena Inc.
- Senior Management
-
Michael F Mahoney, Chmn. & CEO
Daniel J Brennan, EVP, CFO
Ian Meredith, EVP, Global CMO
Edward Mackey, MD, PhD, EVP, Global Operations - Contact Info
-
Boston Scientific Corp.
Phone: (508) 683-4000
300 Boston Scientific Way
Marlborough, MA 01752-1234
USA
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice